The World Health Organization declared severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) a pandemic in March 2020. Since then, there have been numerous waves of COVID-19 infection and evolving viral strains. There is accumulating evidence of worse prognoses for people with COVID-19 and existing comorbidities, and a link between acute COVID-19 and new onset cardiovascular disease (CVD) and diabetes mellitus (DM) has been identified. However, it is currently not clear whether COVID-19 has longer-term effects on cardiometabolic risk.

In a recent study published in PLOS Medicine, Dr Rezel-Potts and colleagues aimed to determine whether the incidence of new CVD and DM increased over a 12-month period in people with COVID-19 compared with matched healthy controls in a large UK-based cohort. Clear distinctions on the different stages of COVID-19 infection were defined as: ‘acute COVID-19’ (first 4 weeks after infection), ‘post-acute COVID-19’ (5 to 12 weeks after infection) and ‘long COVID-19’ (symptomatic for more than 12 weeks after infection).



Sign up for a free ASCEND account to continue reading.

ASCEND provides CME-accredited content designed to improve the care of people living with diabetes and obesity worldwide. Watch experts share their clinical insights, talk through case studies, address frequently asked questions, and much more!

Already a member? Login